Breaking News Instant updates and real-time market news.

ATHN

Athenahealth

$120.92

-1.03 (-0.84%)

06:28
10/12/18
10/12
06:28
10/12/18
06:28

Athenahealth reaching out to previously rejected suitors, NY Post reports

Athenahealth, which is under pressure by Elliott Management's Paul Singer to put itself on the block, has recently approached suitors it previously rejected as stronger offers have failed to materialize, the New York Post reports, citing sources. Elliott, which forced out Athena founder and CEO Jonathan Bush in June, previously said it would pay $160 a share for the company, or roughly $7B, but has since backed off that offer and bids are now believed to value the company at no greater than $135 a share with Elliott's bid not the highest among them. Reference Link

ATHN Athenahealth
$120.92

-1.03 (-0.84%)

09/19/18
DBAB
09/19/18
NO CHANGE
Target $140
DBAB
Hold
Athenahealth price target lowered to $140 from $170 at Deutsche Bank
Deutsche Bank analyst Glen Santangelo yesterday afternoon lowered his price target for Athenahealth to $140 from $170 saying the "inconsistent" media reports raise uncertainty in the company's sale process. The analyst would not be surprised to eventually learn that the process has not generated the robust interest level management had originally hoped. However, he still believes a sale is the most likely outcome and in the best interest of shareholders. In light of the new information, the market will begin to expect potential bids to be closer to $150 per share, Santangelo told investors in a research note. He expects the stock to trade at a 5%-10% discount to the potential $150 takeout price and keeps a Hold rating on Athenahealth.
09/19/18
LEER
09/19/18
NO CHANGE
LEER
Market Perform
Leerink sees risk of Athenahealth returning to $125 share level
Leerink analyst David Larsen is more cautious on Athenahealth following news reports that Elliott Management may be backing away from its original $160 per share offer and other potential acquirers have "gone quiet." The analyst believes Elliott's initial offer was meant mainly to initiate a sales process, consistent with its prior activist campaigns. Without other serious bidders emerging, Larsen says he has reduced conviction that Athenahealth will sell for above $160 per share. He sees greater risk that the shares return to the $125 level and keeps a Market Perform rating on the name.
09/26/18
STFL
09/26/18
NO CHANGE
Target $140
STFL
Hold
Athenahealth buyout at $130-$150 more likely if no strategic buyer, says Stifel
Commenting on multiple conflicting media reports from "unnamed sources" about the likelihood of an Athenahealth transaction, Stifel analyst David Grossman said he continues to view an LBO as the higher probability outcome. In the absence of a strategic buyer, $160 would be the upper-end of the potential buyout range, but a price in the range of $130-$150 is "more likely," he tells investors. Grossman keeps a Hold rating and $140 price target on Athenahealth shares.
09/28/18
RBCM
09/28/18
NO CHANGE
Target $140
RBCM
Sector Perform
Athenahealth price target lowered to $140 from $160 at RBC Capital
RBC Capital analyst George Hill lowered his price target on Athenahealth to $140 and kept his Sector Perform rating amid the latest CNBC reports of "multiple bids" coming from potential strategic acquirers. The analyst states that the speculation around bid prices coming below Elliott Management's prior "soft $160" per share bid, along with earlier reports of his reduced interest following due diligence, suggest that the bid price could be around the company's current trading price. Hill further notes that the reported interest could force the board to decide on whether to accept the bids within weeks.

TODAY'S FREE FLY STORIES

PLAB

Photronics

$11.34

-0.05 (-0.44%)

06:27
02/21/19
02/21
06:27
02/21/19
06:27
Earnings
Photronics sees Q2 diluted EPS 3c-10c, consensus 10c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

, GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

06:26
02/21/19
02/21
06:26
02/21/19
06:26
Periodicals
Sen. Warner slams Google for Nest's hidden microphone, Business Insider reports »

Virginia Sen. Mark…

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

PLAB

Photronics

$11.34

-0.05 (-0.44%)

06:26
02/21/19
02/21
06:26
02/21/19
06:26
Earnings
Photronics reports Q1 EPS 8c, consensus 5c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TPC

Tutor Perini

$17.72

0.25 (1.43%)

06:25
02/21/19
02/21
06:25
02/21/19
06:25
Hot Stocks
Tutor Perini awarded $253M contract by MTA New York City Transit »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

STNG

Scorpio Tankers

$19.66

-0.28 (-1.40%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Conference/Events
Scorpio Tankers management to meet with BTIG »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Hot Stocks
Dine Brands board approves 10% increase to quarterly dividend to 69c per share »

The company's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GMDA

Gamida Cell

$13.46

0.01 (0.07%)

06:23
02/21/19
02/21
06:23
02/21/19
06:23
Hot Stocks
Gamida Cell presents new data from NAM-NK and NiCord programs »

Gamida Cell announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Earnings
Dine Brands sees FY19 adjusted EPS $6.90-$7.20, consensus $6.93 »

Applebee's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LPCN

Lipocine

$1.71

(0.00%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Lipocine management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KURA

Kura Oncology

$15.06

-0.22 (-1.44%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Kura Oncology management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Earnings
Dine Brands reports Q4 adjusted EPS $1.70, consensus $1.57 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JSAIY

J Sainsbury

$0.00

(0.00%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Downgrade
J Sainsbury rating change  »

J Sainsbury downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$34.71

0.475 (1.39%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
Knight-Swift management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KIDS

OrthoPediatrics

$38.34

0.96 (2.57%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
OrthoPediatrics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Mar

  • 27

    Mar

GDOT

Green Dot

$74.69

-0.05 (-0.07%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Green Dot analyst commentary  »

Green Dot Q4 margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$97.13

0.18 (0.19%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Grand Canyon analyst commentary  »

Grand Canyon correction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$89.52

1.55 (1.76%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Conference/Events
Kadant management to meet with Barrington »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SCBFF

Standard Chartered

$0.00

(0.00%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Periodicals
Standard Chartered earmarks $900M for U.S., UK fines, FT reports »

Standard Chartered has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
Breaking Earnings news story on PQ Group »

PQ Group sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
PQ Group sees FY19 revenue $1.64B-$1.67B, consensus $1.68B »

Sees FY19: Adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Earnings
PQ Group reports Q4 adjusted EPS 17c, consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TEF

Telefonica

$8.73

0.07 (0.81%)

, TIGO

Millicom

$60.25

(0.00%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Hot Stocks
Millicom buys Telefonica mobile businesses in Central America for $1.65B »

Millicom International…

TEF

Telefonica

$8.73

0.07 (0.81%)

TIGO

Millicom

$60.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 12

    Mar

  • 19

    Mar

  • 19

    Mar

HTGC

Hercules Capital

$13.12

0.07 (0.54%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Hot Stocks
Hercules Capital names Seth Meyer as CFO »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JOUT

Johnson Outdoors

$65.68

-0.23 (-0.35%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Conference/Events
Johnson Outdoors management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 28

    Feb

  • 28

    Feb

CGC

Canopy Growth

$46.18

-0.2 (-0.43%)

06:14
02/21/19
02/21
06:14
02/21/19
06:14
Recommendations
Canopy Growth analyst commentary  »

Piper Jaffray remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.